ArticleOncology letters2025
Breast mucoepidermoid carcinoma: A case report.
Article in Oncology letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A clinicopathologic and survival analysis of mucoepidermoid carcinoma of the breast.Contemporary oncology (Poznan, Poland) · 2026Article
- Seven Shades of Triple Negativity: A Review Unveiling the Low-Grade Spectrum of Breast Cancer.Cancers · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The present study reports the case of a 43-year-old female patient who underwent surgical excision of a right breast mass. Gross examination revealed a cystic lesion. Histopathological examination demonstrated a solid cystic tumor with intraluminal papillary projections. The neoplasm was composed of mildly atypical intermediate, epidermoid, mucinous and eosinophilic cells, exhibiting cribriform glandular patterns, and microcystic structures containing mucinous or eosinophilic secretions. Peritumoral lymphoid hyperplasia was observed in adjacent mammary gland tissue. Immunohistochemical results showed that p63, cytokeratin (CK) 5/6 and CK7 exhibited zonal positive staining; GATA binding protein 3 was positive; S-100 and SYN were negative; the estrogen receptor positive rate was 20%; progesterone receptor was negative; human epidermal growth factor receptor 2 was 1+; and the Ki-67 positive index was ~10%. Fluorescence
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.